rs267606978
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_016203.4(PRKAG2):c.1516G>C(p.Glu506Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_016203.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRKAG2 | NM_016203.4 | c.1516G>C | p.Glu506Gln | missense_variant | Exon 14 of 16 | ENST00000287878.9 | NP_057287.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The E506Q likely pathogenic variant in the PRKAG2 gene has been reported in an infant with ventricular pre-excitation and severe biventricular hypertrophic cardiomyopathy, and was found to segregate with a cardiomyopathy phenotype in two relatives (Kelly et al., 2009). In addition, E506Q is classified in ClinVar as a likely pathogenic variant by an external clinical laboratory that identified this variant de novo in an individual with cardiomyopathy; the variant also segregated with disease in one additional family member (SCV000204030.3; Landrum et al., 2016). This variant was also identified in our laboratory in an individual with HCM and segregated with the phenotype in one family member. Furthermore, the E506Q variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. E506Q is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. Furthermore, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Finally, a different missense variant at the same residue (E506K) has been identified as likely pathogenic by GeneDx as well as reported in the Human Gene Mutation Database in association with cardiomyopathy (Stenson et al., 2014), thus supporting the functional importance of this region of the protein. -
Hypertrophic cardiomyopathy 6 Pathogenic:1
- -
Hypertrophic cardiomyopathy Pathogenic:1
proposed classification - variant undergoing re-assessment, contact laboratory -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at